Buehlmann


Glomerular Filtration Rate

 

Cystatin c

BÜHLMANN signs worldwide OEM agreement for Gentian’s Cystatin C immunoassay. The Gentian Cystatin C immunoassay has been shown to be superior to other Cystatin C tests due to its assay design, using avian antibodies to capture Cystatin C from serum. It was shown that the assay correlates excellently with the iohexol clearance, which is regarded as a reference method.

Glomerular filtration Rate

testMany studies confirmed that Cystatin C is a reliable marker for Glomerular filtration rate (GFR) assessment. 3 ul of blood sample are required to run the BÜHLMANN Cystatin C assay on routine clinical analysers.

Various methods based on Creatinine are being widely used to assess the GFR. However, all of them often lead to over or under estimation of the GFR and thus has to be adjusted by various factors including age, gender, diet, muscle mass and race. Unlike creatinine serum Cystatin C is virtually unaffected by these factors and very simple formulas can be used to obtain a reliably estimated GFR.

A number of well documented studies comparing creatinine or creatinine based GFR estimations and Cystatin C have shown Cystatin C to be superior to creatinine. In particular, Creatinine based assesments of GFR have a lack of sensitivity until stage 2 and 3 of renal disease. Cystatin C does not have this “blind area”, thus GFR changes can be detected earlier when intervention might improve outcomes. Cystatin C values are already elevated when creatinine is still within the normal range.

A Cystatin C based GFR calculation can directly be performed on www.gfrcalc.com

The Cystatin C Kit from BÜHLMANN provides liquid, ready to use reagents offering a maximum convenience and accuracy. The calibrator and controls are included in the kits and CE-marked applications are available upon request. Due to the use of avian antibodies no interference through rheumatic factors are detectable.

For further information see Dossier: Chronic Kidney Disease

Product Information

Cystatin

Method

PETIA

Time to results

10 min

Sample Type

2 µl plasma, serum

Standard range

0.25-8.0 mg/ml

Sensitivity

0.33 mg/ml

Order Code

KK-CYC 
KK-CYC-6
FDA CE

* Multilingual document [EN, DE,  FR, IT, ES]

DOWNLOADS

Instruction 
for use*      

Clinical Information

Technical Information

English

PDF [300Kb] PDF [350Kb] PDF [600Kb]

Contact

BÜHLMANN Laboratories AG
Baselstr. 55
CH-4124 Schönenbuch
Switzerland
Fon: +41 61 487 12 12
Fax: +41 61 487 12 34
info@buhlmannlabs.ch

Your local distributor
Order
About us
Job opportunities

News

NEW OWN CALPROTECTIN REIMBURSEMENT POSITION IN SWITZERLAND

BÜHLMANN is very proud to announce that the calprotectin determination in stool starting from January 1st 2012, has an official new position in the reimb  more

New Seegene DPO Movie showing how this unique and proprietary technology is working to allow innovative multiplexing.

The unique and proprietary DPO™(Dual-Priming-Oligonucleotide) technology is the corner stone for all of the Seegene products, and it is the key to achieve  more

New EntroGen BRAF test (V600E/K/D) for the detection of important mutations found in melanoma on your real-time PCR instrument.

EntroGen has a new BRAF test that detects, beside the V600E mutation, also the V600K and the V600D, which are important mutations found in melanoma.   more

BÜHLMANN innovations and news at the JIB

At the JIB Congress in Paris, 8th – 10th November 2011, BÜHLMANN presents the MDx products of EntroGen and AutoGenomics as well as new developments of its  more

Get our RSS - Feed